Showing results (391-400 of 398) with videos related to
Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 398 results.
The New England Journal of Medicine|August 21, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell CarcinomaToni K Choueiri, Thomas Powles, Katriina Peltola, et al.Oncotarget|January 5, 2017
Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancerJae-Han Kim, Sung Hyeon Lee, Sookyung Choi, et al.Genome Medicine|February 20, 2020
Comprehensive pharmacogenomic characterization of gastric cancerJason K Sa, Jung Yong Hong, In-Kyoung Lee, et al.Oncology (Williston Park, N.Y.)|April 27, 2023
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal AdenocarcinomaDaniel Vt Catenacci, Yoon-Koo Kang, Hope E Uronis, et al.Journal for Immunotherapy of Cancer|April 9, 2026
Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib studyJose Luis Perez-Gracia, Begoña Mellado, Aaron Richard Hansen, et al.The Lancet. Oncology|July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trialDaniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.Targeted Oncology|October 1, 2024
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV StudyOndřej Fiala, Francesco Massari, Umberto Basso, et al.Pageof 40